AXACTOR ASA financials
AXACTOR ASA
549300P5VT8OMA17TJ33 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Operating expenses | €118.7M | €124.8M |
| Employee benefits expense | €63.5M | €66.6M |
| Operating profit (EBIT) | -€2.3M | €122.8M |
| Net finance income / (cost) | -€82.8M | -€81.4M |
| Finance costs | €91.2M | €84.8M |
| Income tax expense | -€6.0M | €7.9M |
| Profit for the year | -€79.1M | €27.6M |
| — attributable to owners | -€79.5M | €30.8M |
| — attributable to NCI | €466.0K | -€3.2M |
| Total comprehensive income | -€92.1M | €13.5M |
| Per share | ||
| Basic EPS | €-0.26 | €0.10 |
| Diluted EPS | €-0.26 | €0.10 |
| Cash flow statement | ||
| Cash generated from operations | €267.8M | €209.4M |
| Net cash from operating activities | €139.2M | €89.3M |
| Income taxes paid | €23.6M | €11.6M |
| Net cash from investing activities | -€3.1M | -€3.9M |
| Net cash from financing activities | -€133.2M | -€85.5M |
| Proceeds from borrowings | €42.0M | €343.3M |
| Repayments of borrowings | €89.3M | €341.9M |
| Lease liability payments | €3.7M | €3.1M |
| Net change in cash | €2.9M | -€24.0K |
| Balance sheet | ||
| Total assets | €1.27B | €1.44B |
| Non-current assets | €1.18B | €1.36B |
| Property, plant & equipment | €1.8M | €2.0M |
| Right-of-use assets | €7.8M | €11.6M |
| Intangible assets & goodwill | €58.9M | €59.8M |
| Current assets | €83.9M | €70.9M |
| Trade & other receivables | €7.7M | €6.6M |
| Cash & equivalents | €33.0M | €31.8M |
| Total equity | €331.7M | €423.5M |
| Non-controlling interests | -€9.2M | -€9.7M |
| Non-current liabilities | €898.2M | €961.4M |
| Long-term borrowings | €884.7M | €939.1M |
| Lease liabilities (non-current) | €7.1M | €9.0M |
| Current liabilities | €35.8M | €50.9M |
| Lease liabilities (current) | €3.3M | €3.2M |
| Deferred tax liabilities | €1.8M | €10.5M |
| Derived metrics | ||
| Return on equity | -23.8% | 6.5% |
| Cash conversion ratio | -1.76× | 3.24× |
| Other reported items | ||
| Accumulated Other Comprehensive Income | -€36.1M | -€23.1M |
| Additional Paidin Capital | €271.0M | €270.8M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €11.6M | €9.1M |
| Adjustments For Fair Value Gains Losses | €120.0K | -€1.8M |
| Adjustments For Sharebased Payments | €382.0K | €450.0K |
| Basic Earnings Loss Per Share From Continuing Operations | €-0.26 | €0.11 |
| Comprehensive Income Attributable To Noncontrolling Interests | €466.0K | -€3.2M |
| Comprehensive Income Attributable To Owners of Parent | -€92.5M | €16.7M |
| Current Restricted Cash and Cash Equivalents | €1.9M | €2.6M |
| Current Tax Liabilities Current | €2.4M | €12.2M |
| Deferred Tax Assets | €12.3M | €8.5M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €11.6M | €9.1M |
| Diluted Earnings Loss Per Share From Continuing Operations | €-0.26 | €0.11 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€1.8M | -€802.0K |
| Equity and Liabilities | €1.27B | €1.44B |
| Finance Income | €8.4M | €3.4M |
| Gains Losses On Cash Flow Hedges Net of Tax | -€407.0K | €0 |
| Gains Losses On Financial Assets At Amortised Cost | -€152.3M | -€13.1M |
| Increase Decrease In Working Capital | €6.9M | €2.9M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | — | -€992.0K |
| Increase Decrease Through Sharebased Payment Transactions | €218.0K | €450.0K |
| Intangible Assets Other Than Goodwill | €12.0M | €15.1M |
| Interest Paid Classified As Financing Activities | €87.5M | €67.7M |
| Issued Capital | €158.4M | €158.4M |
| Liabilities | €934.0M | €1.01B |
| Other Comprehensive Income | -€13.0M | -€14.1M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€9.4M | -€10.5M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€6.0K | -€48.0K |
| Other Current Assets | €37.2M | €27.2M |
| Other Current Liabilities | €26.2M | €31.4M |
| Other Expense By Nature | €53.5M | €56.5M |
| Other Noncurrent Financial Assets | €1.4M | €2.5M |
| Other Noncurrent Liabilities | €4.6M | €2.7M |
| Other Revenue | €54.2M | €55.8M |
| Payments For Debt Issue Costs | €117.0K | €15.4M |
| Payments From Changes In Ownership Interests In Subsidiaries | €0 | €992.0K |
| Profit Loss From Continuing Operations | -€79.1M | €33.6M |
| Profit Loss From Discontinued Operations | €0 | -€6.0M |
| Reclassification Adjustments On Cash Flow Hedges Net of Tax | €3.2M | €3.6M |
| Retained Earnings | -€52.5M | €27.1M |
| Revenue and Operating Income | €127.9M | €256.6M |
| Revenue From Interest | €222.0M | €211.3M |
| Trade and Other Current Payables To Trade Suppliers | €3.9M | €4.1M |
Every line item above is a fact tagged in AXACTOR ASA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.